Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, United States.
ACS Chem Biol. 2011 Oct 21;6(10):1041-51. doi: 10.1021/cb200178w. Epub 2011 Jul 27.
Cells are known to take up molecules through membrane transport mechanisms such as active transport, channels, and facilitated transport. We report here a new membrane transport mechanism that employs neither cellular energy like active transport nor a preexisting electrochemical gradient of the free substrate like channels or facilitated transport. Through this mechanism, cells take up vitamin A bound with high affinity to retinol binding protein (RBP) in the blood. This mechanism is mediated by the RBP receptor STRA6, which defines a new type of cell-surface receptor. STRA6 is essential for the proper functioning of multiple human organs, but the mechanisms that enable and control its cellular vitamin A uptake activity are unknown. We found that STRA6-mediated vitamin A uptake is tightly coupled to specific intracellular retinoid storage proteins, but no single intracellular protein is absolutely required for its transport activity. By developing sensitive real-time monitoring techniques, we found that STRA6 is not only a membrane receptor but also catalyzes vitamin A release from RBP. However, vitamin A released from RBP by STRA6 inhibits further vitamin A release by STRA6 unless specific intracellular retinoid storage proteins relieve this inhibition. This mechanism is responsible for its coupling to intracellular storage proteins. The coupling of uptake to storage provides high specificity in cellular uptake of vitamin A and prevents the excessive accumulation of free vitamin A. We have also identified a robust small-molecule-based technique to specifically stimulate cellular vitamin A uptake. This technique has implications in treating human diseases.
细胞通过膜转运机制摄取分子,例如主动转运、通道和易化转运。我们在这里报告一种新的膜转运机制,它既不利用细胞能量(如主动转运),也不利用游离底物的预先存在的电化学梯度(如通道或易化转运)。通过这种机制,细胞摄取与血液中视黄醇结合蛋白 (RBP) 高亲和力结合的维生素 A。这种机制是由 RBP 受体 STRA6 介导的,它定义了一种新型的细胞表面受体。STRA6 对于多个人体器官的正常功能至关重要,但使它能够并控制其细胞维生素 A 摄取活性的机制尚不清楚。我们发现 STRA6 介导的维生素 A 摄取与特定的细胞内类视黄醇储存蛋白紧密偶联,但没有单一的细胞内蛋白对其转运活性绝对必需。通过开发敏感的实时监测技术,我们发现 STRA6 不仅是一种膜受体,而且还催化 RBP 中维生素 A 的释放。然而,STRA6 从 RBP 释放的维生素 A 会抑制 STRA6 进一步释放维生素 A,除非特定的细胞内类视黄醇储存蛋白解除这种抑制。这种机制负责与细胞内储存蛋白的偶联。摄取与储存的偶联为细胞摄取维生素 A 提供了高度特异性,并防止游离维生素 A 的过度积累。我们还鉴定了一种基于小分子的稳健技术,可特异性刺激细胞维生素 A 摄取。这种技术对治疗人类疾病具有重要意义。